NYMXF (Nymox Pharmaceutical) Total Inventories: $0.00 Mil (As of Dec. 2024)

What is Nymox Pharmaceutical Total Inventories?

Nymox Pharmaceutical NYMXF +9.09% Total Inventories is $0.00 Mil as of Dec. 2024.

Nymox Pharmaceutical's total inventories for the quarter that ended in Dec. 2024 was $0.00 Mil. Nymox Pharmaceutical's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Nymox Pharmaceutical's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-0.08.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nymox Pharmaceutical (OTCPK:NYMXF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Nymox Pharmaceutical's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.074	+	0.75 * 0	+	0.5 * 0	-	7.429
-	0	-	0)	/	94.540
=	-0.08

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nymox Pharmaceutical's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nymox Pharmaceutical's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	0	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nymox Pharmaceutical's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Nymox Pharmaceutical Total Inventories Related Terms

Nymox Pharmaceutical Total Inventories Historical Data

* Premium members only.

The historical data trend for Nymox Pharmaceutical's Total Inventories can be seen below:

Nymox Pharmaceutical Total Inventories Chart

Nymox Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

0.03

0.00

Nymox Pharmaceutical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

Nymox Pharmaceutical Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of $0.00 Mil mean?

Nymox Pharmaceutical (NYMXF) has a Total Inventories of $0.00 Mil as of Dec. 2024. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nymox Pharmaceutical and its competitors.

Is Nymox Pharmaceutical's Total Inventories too high?

Nymox Pharmaceutical's current Total Inventories is $0.00 Mil.

How does Nymox Pharmaceutical's Total Inventories compare to LYRA and RNAZ?

Nymox Pharmaceutical's Total Inventories of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Biotechnology company?

A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Nymox Pharmaceutical and its competitors. Nymox Pharmaceutical's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nymox Pharmaceutical stock overvalued right now?

Nymox Pharmaceutical (NYMXF) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For Nymox Pharmaceutical (NYMXF), the current Total Inventories is $0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nymox Pharmaceutical Business Description

Industry Healthcare Biotechnology

Comparable Companies LYRA RNAZ TOVX ADIL CDIO ACXP NKGN APRE KALA SLXN VRTX REGN ASX:CSL XKRX:207940 ALNY XBRU:UCB XBRU:ARGX INSM ONC XKRX:068270

Address Bay & Deveaux Streets, Nassau, BHS

Website https://www.nymox.com

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug as well as other therapeutic and diagnostic indications. It also has U.S. and patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment, focused on researching and developing products for the aging population.